FIELD: medicine.
SUBSTANCE: group of inventions refers to methods and systems of analysis based on enzymatic degradation following protein-protein interaction for reporter modulation (activation or inactivation).
EFFECT: group of inventions provides simple high-efficiency identification of protein-protein interaction modelling.
34 cl, 17 dwg, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| YEAST PROTEIN DISPLAY IN THE PERIPLASMATIC SPACE | 2018 |
|
RU2802770C2 |
| COMPOSITIONS AND METHODS RELATED TO SOLUBLE G-PROTEIN CONJUGATE RECEPTORS (SGPCR) | 2006 |
|
RU2423378C2 |
| G-PROTEIN COUPLED RECEPTORS DROSOPHILA, NUCLEIC ACIDS AND RELATED METHODS | 2003 |
|
RU2326385C2 |
| CELL | 2016 |
|
RU2729158C2 |
| METHOD OF SCREENING GAMMA-SECRETASE INHIBITORS | 2004 |
|
RU2373284C2 |
| COMPOSITION OF COMPLEMENTING FRAGMENTS OF MOLECULE OF PHOTOPROTEINS FROM HYDROZOA AND METHOD OF ITS APPLICATION FOR ANALYSIS OF INTERMOLECULAR INTERACTIONS | 2009 |
|
RU2418859C1 |
| FUSION PROTEINS AND METHODS OF TREATMENT, PREVENTION OR ALLEVIATION OF PAIN | 2013 |
|
RU2652954C2 |
| G-PROTEIN-CONJUGATED RECEPTOR WHICH HAVING ALTERED LIGAND AFFINITY AND APPLICATION THEREOF | 2008 |
|
RU2468035C2 |
| THERAPEUTIC FUSION PROTEINS | 2012 |
|
RU2651492C2 |
| TRANSGENIC ANIMAL THAT DIFFERS FROM HUMAN, AND ITS APPLICATION | 2010 |
|
RU2579701C2 |
